Antony Koblish, co-founder and CEO of TELA Bio, a medtech company focused on solving the issues related to hernia repair and soft tissue reconstruction, discusses OviTex®, a next generation mesh that features the safety and naturalness of biologic material and the strength and durability of synthetic mesh. TELA Bio worked with 100+ general and plastic surgeons to purposefully design a portfolio of soft-tissue repair solutions that provide a more natural hernia repair option.
Antony Koblish is a medical device entrepreneur with 25 years of experience in health care. Prior to founding TELA Bio Mr. Koblish was President and Chief Executive Officer of Orthovita Inc. a publicly traded orthobiologics and biosurgery medical device company. During his tenure as Chief Executive Officer of Orthovita from 2002 to 2011 Mr. Koblish created significant company value growing valuation from $30M to a $316M exit sale to Stryker Corporation in 2011. He is a skilled leader with a proven track record in driving sales growth building a robust product pipeline establishing world-class commercial operations and instilling clinical and manufacturing quality. Mr. Koblish is also a co-founder and currently serves as Chairman of the Board of Onkos Surgical Inc. a surgical oncology company and is an operating partner with 1315 Capital a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical medical technology and health care services companies. Mr. Koblish earned a Master of Science in Engineering degree in Mechanical Engineering and Applied Mechanics from the University of Pennsylvania and holds a Bachelor of Science degree in Mechanical Engineering from Worcester Polytechnic Institute.